HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Min Zheng Selected Research

karyopherin alpha 2

1/2018KPNA2 promotes migration and invasion in epithelial ovarian cancer cells by inducing epithelial-mesenchymal transition via Akt/GSK-3β/Snail activation.
6/2017KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis.
9/2015MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Min Zheng Research Topics

Disease

150Neoplasms (Cancer)
06/2022 - 07/2004
48Infections
01/2022 - 06/2004
37Psoriasis (Pustulosis Palmaris et Plantaris)
10/2022 - 12/2003
36Inflammation (Inflammations)
10/2022 - 11/2003
31Hepatocellular Carcinoma (Hepatoma)
01/2022 - 08/2002
30Neoplasm Metastasis (Metastasis)
06/2022 - 08/2002
24Carcinogenesis
01/2021 - 04/2008
19Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 04/2010
18Fibrosis (Cirrhosis)
12/2022 - 04/2002
14Carcinoma (Carcinomatosis)
10/2019 - 08/2002
13Breast Neoplasms (Breast Cancer)
01/2022 - 04/2008
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 12/2016
9Lymphatic Metastasis
06/2022 - 02/2010
9Virus Diseases (Viral Diseases)
01/2022 - 03/2011
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 01/2004
9Liver Neoplasms (Liver Cancer)
10/2020 - 08/2002
8Necrosis
12/2022 - 04/2008
8Liver Cirrhosis (Hepatic Cirrhosis)
12/2022 - 11/2003
8Lung Neoplasms (Lung Cancer)
01/2022 - 02/2008
8Hypoxia (Hypoxemia)
12/2021 - 04/2008
7Liver Diseases (Liver Disease)
08/2021 - 01/2017
7Squamous Cell Carcinoma of Head and Neck
04/2020 - 07/2009
7Diabetic Nephropathies (Diabetic Nephropathy)
01/2018 - 01/2011
6COVID-19
01/2022 - 11/2020
6Adenoid Cystic Carcinoma (Cylindroma)
01/2021 - 11/2010
6Glioma (Gliomas)
01/2020 - 01/2014
5Colitis
05/2022 - 01/2013
5Fever (Fevers)
06/2021 - 08/2009
5Myocardial Infarction
05/2021 - 01/2004
5Chronic Renal Insufficiency
01/2021 - 03/2012
5Type 2 Diabetes Mellitus (MODY)
01/2021 - 06/2011
5Ovarian Epithelial Carcinoma
07/2020 - 10/2010
4Stroke (Strokes)
01/2022 - 01/2009
4Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 07/2004
4Ischemia
01/2022 - 08/2010
4Heart Failure
12/2021 - 01/2012
4Reperfusion Injury
05/2021 - 05/2003
4Chronic Hepatitis B
01/2021 - 04/2004
4Human Influenza (Influenza)
01/2020 - 09/2011

Drug/Important Bio-Agent (IBA)

65Proteins (Proteins, Gene)FDA Link
06/2022 - 08/2002
31Biomarkers (Surrogate Marker)IBA
10/2022 - 05/2010
30Messenger RNA (mRNA)IBA
01/2020 - 04/2002
25Pharmaceutical PreparationsIBA
01/2022 - 06/2008
23CytokinesIBA
01/2022 - 03/2011
17MicroRNAs (MicroRNA)IBA
01/2021 - 05/2008
13DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2006
13Transcription Factors (Transcription Factor)IBA
04/2020 - 11/2010
13Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2019 - 07/2006
12RNA (Ribonucleic Acid)IBA
01/2021 - 04/2004
11EnzymesIBA
10/2022 - 11/2003
11InflammasomesIBA
01/2022 - 01/2018
11Glucose (Dextrose)FDA LinkGeneric
12/2021 - 12/2007
9Biological ProductsIBA
01/2019 - 02/2013
8Antiviral Agents (Antivirals)IBA
10/2022 - 03/2010
8Therapeutic UsesIBA
01/2022 - 04/2006
8Long Noncoding RNAIBA
08/2020 - 06/2014
8Small Interfering RNA (siRNA)IBA
01/2020 - 09/2008
8Focal Adhesion Protein-Tyrosine KinasesIBA
07/2013 - 04/2008
7Interleukin-6 (Interleukin 6)IBA
01/2022 - 02/2014
7CarbonIBA
12/2021 - 11/2015
7Peptidylprolyl Isomerase (Prolyl Isomerase)IBA
01/2020 - 04/2015
7Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2020 - 06/2015
7AntigensIBA
01/2019 - 01/2009
7Hyaluronic Acid (Hyaluronan)IBA
09/2013 - 12/2002
7Phosphotransferases (Kinase)IBA
07/2013 - 04/2008
6LipidsIBA
01/2022 - 07/2014
6PlatinumIBA
01/2022 - 02/2014
6LipopolysaccharidesIBA
12/2021 - 01/2014
6Indicators and Reagents (Reagents)IBA
01/2020 - 10/2010
5LigandsIBA
01/2022 - 03/2010
5VaccinesIBA
12/2021 - 08/2009
5Anti-Bacterial Agents (Antibiotics)IBA
05/2021 - 11/2011
5AntioxidantsIBA
05/2021 - 01/2017
5Bile Acids and Salts (Bile Acids)IBA
04/2021 - 01/2017
5Cadherins (E-Cadherin)IBA
04/2021 - 04/2014
5ChemokinesIBA
01/2021 - 05/2011
5SolutionsIBA
10/2020 - 05/2010
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2020 - 01/2007
5CateninsIBA
01/2020 - 04/2014
5Reactive Oxygen Species (Oxygen Radicals)IBA
10/2019 - 04/2008
5CollagenIBA
01/2019 - 01/2013
5squamous cell carcinoma-related antigenIBA
12/2018 - 01/2007
5Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2018 - 12/2003
4Monoclonal AntibodiesIBA
01/2022 - 08/2008
4Sorafenib (BAY 43-9006)FDA Link
01/2022 - 05/2017
4Histones (Histone)IBA
05/2021 - 01/2017
4Doxorubicin (Adriamycin)FDA LinkGeneric
05/2021 - 01/2012
4Interferon Type IIBA
01/2021 - 03/2011
4Etanercept (Enbrel)FDA Link
08/2020 - 01/2016
4ceric oxide (cerium dioxide)IBA
12/2019 - 11/2018
4Peptides (Polypeptides)IBA
12/2018 - 12/2002

Therapy/Procedure

69Therapeutics
06/2022 - 04/2003
19Drug Therapy (Chemotherapy)
01/2022 - 02/2008
7Radiotherapy
10/2019 - 09/2008
6Photochemotherapy (Photodynamic Therapy)
01/2022 - 04/2013
6Immunotherapy
01/2022 - 01/2019
6Hysterectomy
03/2021 - 04/2010
6Transplantation
12/2017 - 01/2004
5Lasers (Laser)
01/2022 - 01/2003
4Injections
10/2020 - 04/2010